Quarterly report · Q1
9627.TEDINET S100P6MT
Period2022-05-01 → 2022-07-31
Filed2022-09-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥81.5bn | 2022-05-01 → 2022-07-31 | Cons. | Net sales |
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥75.0bn | 2021-05-01 → 2021-07-31 | Cons. | Net sales |
| Operating income | ¥2.8bn | 2022-05-01 → 2022-07-31 | Cons. | Operating income |
| Operating income | ¥2.6bn | 2021-05-01 → 2021-07-31 | Cons. | Operating income |
| Ordinary income | ¥3.1bn | 2022-05-01 → 2022-07-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.9bn | 2021-05-01 → 2021-07-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.0bn | 2022-05-01 → 2022-07-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.7bn | 2021-05-01 → 2021-07-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.7bn | 2022-05-01 → 2022-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2021-05-01 → 2021-07-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.7bn | 2022-05-01 → 2022-07-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2021-05-01 → 2021-07-31 | Cons. | Profit loss |
| Total assets | ¥228.4bn | at 2022-07-31 | Cons. | Assets |
| Total assets | ¥212.5bn | at 2022-04-30 | Cons. | Assets |
| Total assets | ¥203.6bn | at 2021-07-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥109.6bn | at 2022-07-31 | Cons. | Liabilities |
| Total liabilities | ¥93.5bn | at 2022-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥118.8bn | at 2022-07-31 | Cons. | Net assets |
| Net assets / equity | ¥119.0bn | at 2022-04-30 | Cons. | Net assets |
| Net assets / equity | ¥113.8bn | at 2021-07-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥46.9bn | at 2022-07-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.7bn | at 2022-04-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥48.53 | 2022-05-01 → 2022-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.1 | 2021-05-01 → 2021-07-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 52.0% | at 2022-07-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.9% | at 2021-07-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-05-01 → 2022-07-31 | ¥2.9bn |
| Otherother segments | revenue external | 2022-05-01 → 2022-07-31 | ¥2.9bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2022-07-31 | ¥18m |
| Otherother segments | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2022-07-31 | −¥18m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2022-07-31 | −¥18m |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2022-07-31 | −¥1.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2022-07-31 | ¥72.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2022-07-31 | ¥72.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4.7bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2022-07-31 | ¥6.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2022-07-31 | ¥6.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥164m |
| —segment total | revenue | 2022-05-01 → 2022-07-31 | ¥81.5bn |
| —segment total | revenue external | 2022-05-01 → 2022-07-31 | ¥81.5bn |
| —segment total | revenue intersegment | 2022-05-01 → 2022-07-31 | ¥18m |
| —segment total | segment ordinary income | 2022-05-01 → 2022-07-31 | ¥4.9bn |
| Otherother segments | revenue | 2021-05-01 → 2021-07-31 | ¥3.1bn |
| Otherother segments | revenue external | 2021-05-01 → 2021-07-31 | ¥3.1bn |
| Otherother segments | revenue intersegment | 2021-05-01 → 2021-07-31 | ¥23m |
| Otherother segments | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥13m |
| Reconciling Itemsreconciling | revenue | 2021-05-01 → 2021-07-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-05-01 → 2021-07-31 | −¥23m |
| Reconciling Itemsreconciling | segment ordinary income | 2021-05-01 → 2021-07-31 | −¥1.5bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue | 2021-05-01 → 2021-07-31 | ¥66.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | revenue external | 2021-05-01 → 2021-07-31 | ¥66.8bn |
| jpcrp040300-q1r_E04896-000Dispensing Pharmacyreportable segment | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥4.9bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue | 2021-05-01 → 2021-07-31 | ¥5.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | revenue external | 2021-05-01 → 2021-07-31 | ¥5.1bn |
| jpcrp040300-q1r_E04896-000Drug And Cosmetic Storereportable segment | segment ordinary income | 2021-05-01 → 2021-07-31 | −¥503m |
| —segment total | revenue | 2021-05-01 → 2021-07-31 | ¥75.0bn |
| —segment total | revenue external | 2021-05-01 → 2021-07-31 | ¥75.0bn |
| —segment total | revenue intersegment | 2021-05-01 → 2021-07-31 | ¥23m |
| —segment total | segment ordinary income | 2021-05-01 → 2021-07-31 | ¥4.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 372
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)照内 貴 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新木 亘 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 75011000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 81470000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 316247000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 2864000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 3089000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 16041000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1309000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1704000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 7092000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1274000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1695000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 7126000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 113773000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 118773000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 119010000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 203552000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 228394000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 212461000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 37.10 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 48.53 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 201.47 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.559 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.520 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.560 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35428212 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 35428212 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 35428212 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 35428212 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 300900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 35115800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 351158 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 11512 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 35428212 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 351158 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 300900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 300900 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0085 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |